Home

Publications library


  • Home
    • /
  • Publication Library Listing

Publications

Therapeutic Areas
Patient-Centered Outcomes
Newest to Oldest

Making Use of Technology to Improve Stated Preference Studies

Authors: C Vass, M Boeri, G Shields, J Seo

A delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States

Authors: K M Dahir, E T Rush, S Diaz-Mendoza, P S Kishnani

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine

Authors: R Mangrum, A L Bryant, M T Gerstein, K P McCarrier, C R Houts, J S McGinley, D C Buse, R B Lipton, R J Wirth

Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public-private mix?

Authors: C Berardi, P A Prieto, J Henríquez, F Paolucci

A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH)

Authors: V Saraff, A M Boot, A Linglart, O Semler, P Harvengt, A Williams, K M A Bailey, F Glen, E H Davies, S Wood, S Greentree, A J Rylands

Evaluating treatment choice in patients with moderate to severe psoriasis in the United States: results from a US patient survey

Authors: A W Armstrong, S Jayade, S Rege, N Joshi, V Patel, S Kalirai, D Wolin, K Boyle, D Patel, L Seigel

Development and validation of a photonumeric scale to assess marionette lines

Authors: N Kefalas, S R D Cueto, F Urdiales-Gálvez, L Barry, A Gritti, A Marchac, M Lim, C de la Guardia, G Kerson, M Silberberg

Economic and humanistic burden in paediatric patients with atopic dermatitis

Authors: R Achten, L Van der Rijst, M Piena, H Lamers, F De Beer, M De Bruin-Weller, M De Graaf

Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

Authors: M Boeri, M K Skelsey, J A Schiro, S E Dozier, R Glinert, M M Okun

Real-world use of Ubrogepant as acute treatment for migraine with an anti-calcitonin gene-related peptide monoclonal antibody: results from COURAGE

Authors: R B Lipton, J Contreras-De Lama, D Serrano, E Engstrom, N D Ayasse, W Poh, F Cadiou, A M Adams
View older
Home